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Oxidative Damage to RPA Limits the Nucleotide
Excision Repair Capacity of Human Cells
Melisa Guven1, Reto Brem1, Peter Macpherson1, Matthew Peacock1 and Peter Karran1
Nucleotide excision repair (NER) protects against sunlight-induced skin cancer. Defective NER is associated with
photosensitivity and a high skin cancer incidence. Some clinical treatments that cause photosensitivity can also
increase skin cancer risk. Among these, the immunosuppressant azathioprine and the ﬂuoroquinolone
antibiotics ciproﬂoxacin and oﬂoxacin interact with UVA radiation to generate reactive oxygen species that
diminish NER capacity by causing protein damage. The replication protein A (RPA) DNA-binding protein has a
pivotal role in DNA metabolism and is an essential component of NER. The relationship between protein
oxidation and NER inhibition was investigated in cultured human cells expressing different levels of RPA. We
show here that RPA is limiting for NER and that oxidative damage to RPA compromises NER capability. Our
ﬁndings reveal that cellular RPA is surprisingly vulnerable to oxidation, and we identify oxidized forms of RPA
that are associated with impaired NER. The vulnerability of NER to inhibition by oxidation provides a connection
between cutaneous photosensitivity, protein damage, and increased skin cancer risk. Our ﬁndings emphasize
that damage to DNA repair proteins, as well as to DNA itself, is likely to be an important contributor to skin
cancer risk.
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INTRODUCTION
Skin cancer is one of the few human cancers that are
associated with a well-deﬁned and pervasive mutagen.
Non-melanoma skin cancer genomes are dominated by
the mutational signatures of sunlight-induced DNA lesions
(Alexandrov et al., 2013; Jayaraman et al., 2014; South
et al., 2014). The nucleotide excision repair (NER) system
provides an important protection against skin cancer by
removing potentially mutagenic DNA cyclobutane pyrimi-
dine dimer (CPD) and pyrimidine (6-4) pyrimidone (6-4Py:Py)
photolesions induced by solar UVB radiation. Inefﬁcient NER
in the genetic disorder xeroderma pigmentosum is associated
with photosensitivity and a hugely increased skin cancer risk
(Friedberg et al., 2006).
Photosensitivity and an increased susceptibility to sunlight-
related malignancy are side effects of some medications. For
example, patients prescribed azathioprine for inﬂammatory
bowel disorders or to prevent organ transplant rejection are
UVA photosensitive and have high rates of non-melanoma
skin cancer (Euvrard et al., 2003; Peyrin-Biroulet et al., 2011;
Ramiscal and Brewer, 2013). Azathioprine metabolism
culminates in the incorporation of 6-thioguanine (6-TG) into
patients’ DNA where it acts as a potent UVA photosensitizer.
In cultured human cells, the combination of DNA 6-TG and
UVA generates reactive oxygen species. These cause wide-
spread DNA and protein damage that is associated with
inhibition of DNA repair (Gueranger et al., 2014). Other
photosensitizing drugs include the ﬂuoroquinolone antibiotics
that are photocarcinogens in mice (Itoh et al., 2005) and may
increase skin cancer risk in patients (Traianou et al., 2012).
Combinations of UVA and the ﬂuoroquinolones ciproﬂoxacin
or oﬂoxacin duplicate many of the effects of DNA 6-TG/UVA
in cultured human cells. In particular, ﬂuoroquinolone/UVA
treatment causes DNA and protein damage and inhibits DNA
repair, including NER (Peacock et al., 2014).
Effective NER requires the coordinated activities of numer-
ous proteins to recognize and process DNA lesions. The
human replication protein A (RPA) is an abundant DNA-
binding protein complex that participates in almost all aspects
of DNA metabolism and is essential for NER. Its high-afﬁnity
binding protects single-stranded DNA against nucleases and
facilitates the correct processing of unpaired DNA regions
generated during replication and repair (Binz et al., 2004).
Recruitment of speciﬁc proteins to DNA-bound RPA is
important in the activation of the cellular checkpoints that
maintain genome stability in the face of arrested replication
(Friedel et al., 2009). Consistent with its pivotal role in
protecting DNA, genetic inactivation of murine RPA is lethal,
and haploinsufﬁciency is associated with cancer proneness
and reduced life span (Wang et al., 2005). Reduced RPA
expression in cultured human cells results in spontaneous
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DNA damage and activation of DNA damage–related
checkpoints (Dodson et al., 2004). RFA, the yeast RPA
homolog, is limiting for UV protection, and hypomorphic RFA
mutations confer UVC sensitivity (Umezu et al., 1998) and a
mutator phenotype (Chen et al., 1998).
RPA is a heterotrimer (Wold, 1997). Its subunits of 70, 32,
and 14 kDa (RPA70, RPA32 & RPA14) contain several DNA-
and protein-interacting domains. The most important DNA-
binding motifs lie in the RPA70 subunit. Protein-interacting
domains are located in the N terminus of RPA70 and the C
terminus of RPA32 (Binz et al., 2004). An N-terminal RPA32
domain also contains multiple conserved phosphorylation
sites that control RPA function. RPA32 phosphorylation
triggered by the presence of long single-stranded DNA tracts
at arrested replication forks may serve to regulate the
distribution of limiting RPA resources between replication
and repair (reviewed in Binz et al. (2004)). The role of RPA14
appears to be largely to stabilize the heterotrimer.
We previously showed that protein oxidation is associated
with NER inhibition in human cells treated with 6-TG/UVA or
ﬂuoroquinolone/UVA (Gueranger et al., 2014; Peacock et al.,
2014). Our results suggested that RPA damage might underlie
the reduced NER capability. Here we demonstrate that the
vulnerability of RPA to oxidation confers a risk of suboptimal
NER under oxidative stress conditions. We describe oxidative
RPA lesions in cultured human cells exposed to conditions
that simulate events in the sun-exposed skin of patients taking
azathioprine or ﬂuoroquinolones. Our ﬁndings emphasize the
importance of protein oxidation as a determinant of DNA
repair efﬁciency and skin cancer risk in patients taking
photosensitizing drugs.
RESULTS
RPA expression, NER, and toxicity
Treatment of human cells with 6-TG/UVA inhibits NER
(Gueranger et al., 2014). To investigate how RPA inﬂuences
NER efﬁciency, we compared the removal of UVC-induced 6-
4 Py:Pys by U2OS and the related U2OS-RPA21 cells in
which RPA is overexpressed (Toledo et al., 2013). Western
blotting conﬁrmed an approximately 2-fold RPA overexpres-
sion in U2OS-RPA21 cells (Figure 1a). Increased RPA
protected NER against inhibition by 6-TG/UVA. Whereas 6-
TG/UVA-treated U2OS cells excised o20% of UVC-induced
6-4 Py:Pys in 3 hours, similarly damaged U2OS-RPA21 cells
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Figure 1. Replication protein A (RPA) overexpression, nucleotide excision repair (NER), and sensitivity. (a) Western blotting for RPA14, RPA32, and RPA70. (b)
6:4 Py:Py ELISA of 6-TG-treated U2OS and U2OS-RPA21 cells irradiated with UVA (20 kJ m−2)+10 J m− 2 UVC. (△▲) 10 J m−2 UVC alone. Mean values from
≥3 experiments. (c) Viability of UVA-irradiated cells with Lo (~0.06%) or Hi (~0.14%) DNA 6-thioguanine (6-TG). Mean values from two experiments. (d) 6:4 Py:
Py ELISA of cells treated with ciproﬂoxacin (CIP; 1 hour; 0.5 mM)+UVA (20 kJ m−2)+UVC (10 J m−2). Mean values from ≥3 experiments. (e) As in d, cells treated
with 1 mM oﬂoxacin, UVA+UVC. (f) Ciproﬂoxacin/UVA toxicity. Viability of cells treated for 1 hour with ciproﬂoxacin and UVA (20 kJ m−2). Mean values from
≥3 experiments. (g) Oﬂoxacin/UVA toxicity. As in f, cells were treated with oﬂoxacin and UVA.
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removed ~60% of these photoproducts in the same period
(Figure 1b). U2OS and U2OS-RPA21 cells irradiated with
UVC alone removed 495% of 6-4 Py:Pys in 3 hours.
Increased RPA expression also conferred resistance to the
toxicity of 6-TG/UVA. MTT assays revealed a UVA dose–
dependent decrease in U2OS viability at two levels of DNA 6-
TG substitution. At the higher DNA 6-TG level, approximately
o20% of U2OS cells survived after 20 kJ m−2 UVA. In
contrast, DNA 6-TG-containing U2OS-RPA21 cells were
largely insensitive to UVA, and 480% survived even at the
highest UVA dose (Figure 1c). Treatment with 6-TG or UVA
alone reduced viability by o10%.
6-TG is an atypical photosensitizer in that it is DNA
embedded. The UVA absorbing ﬂuoroquinolone antibiotics
ciproﬂoxacin and oﬂoxacin replicate many of the photo-
sensitizing effects of DNA 6-TG without incorporation into
DNA. In particular, ciproﬂoxacin/UVA and oﬂoxacin/UVA
induce oxidative stress and cause widespread protein damage
that compromises NER (Peacock et al., 2014). 6-4Py:Py ELISA
conﬁrmed that ciproﬂoxacin/UVA and oﬂoxacin/UVA also
inhibited NER in U2OS cells. Increased RPA expression in
U2OS-RPA21 protected against inhibition. Figure 1d shows
that, whereas 500 μM ciproﬂoxacin/20 kJ m− 2 UVA almost
completely abolished 6-4Py:Py excision in U2OS cells,
U2OS-RPA21 cells removed around 50% of these photo-
products within 3 hours under the same conditions. Higher
RPA expression also protected against NER inhibition by
oﬂoxacin/UVA (Figure 1e). 1 mM oﬂoxacin/20 kJ m−2 UVA
that caused a signiﬁcant inhibition of 6-4Py:Py removal in
U2OS cells did not detectably affect excision by U2OS-
RPA21 cells. Repair inhibition was the result of UVA/drug
interaction, and ciproﬂoxacin, oﬂoxacin, or these low UVA
doses alone were without effect.
Increased RPA expression also protected against ﬂuoroqui-
nolone/UVA toxicity. Figure 1f shows that the viability of
UVA-irradiated (20 kJ m− 2) U2OS cells was compromised by
ciproﬂoxacin, and o2% survived treatment with 200 μM. In
contrast, 480% of irradiated U2OS-RPA21 cells survived
treatment with 200 μM ciproﬂoxacin. Oﬂoxacin/UVA was
signiﬁcantly less toxic to both U2OS and U2OS-RPA21 cells.
More than 20% of U2OS cells remained viable following
1,000 μM/20 kJ m− 2, and the effect of RPA overexpression on
U2OS-RPA21 viability was correspondingly more modest
(Figure 1g).
RPA chromatinization
6-TG/UVA generates DNA lesions that are powerful replica-
tion blocks. UVA activation of certain ﬂuoroquinolones
induces To4T CPDs (Lhiaubet-Vallet et al., 2009) that also
arrest replication. As RPA can become sequestered at arrested
replication forks and no longer available for NER, we
investigated recruitment of RPA to chromatin. 6-TG/UVA or
ciproﬂoxacin/UVA reduced recovery of RPA in U2OS cell
extracts (Figure 2a and b). Consistent with RPA chromatiniza-
tion and the presence of replication-arresting DNA lesions,
the missing RPA was recovered by digestion of the extracts
with benzonase (Supplementary Figure S2 online). RPA
recovery from U2OS-RPA21 cells was less affected owing to
their higher RPA levels. As expected, oﬂoxacin/UVA did not
detectably affect RPA recovery in U2OS extracts, as it is a
poor source of CPDs (Peacock et al., 2014; Figure 2b).
Chromatinization of the DDB2 component of the DDB1:
DDB2 (DNA Damage Binding 1:DNA Damage Binding 2)
DNA damage recognition complex is another marker for the
presence of NER substrates (Otrin et al., 1997). Figure 2c
shows that 6-TG/UVA and ciproﬂoxacin/UVA but not
oﬂoxacin/UVA provoked immediate relocalization of a
substantial fraction of DDB2 in U2OS. This observation
provides further conﬁrmation that 6-TG/UVA and ciproﬂox-
acin/UVA induce DNA damage that includes potential
substrates for NER. Oﬂoxacin/UVA is, however, a poor source
of such lesions.
RPA damage
All three photosensitizers cause protein oxidation (Peacock
et al., 2014). As their effects on NER and survival did not
correlate with the induction of DNA lesions, we examined
whether RPA itself was damaged. Western blotting of extracts
from 6-TG/UVA-treated U2OS cells revealed an RPA32
species of ~ 100 kDa (Figure 3a) that was absent from
untreated cells. Western analysis of RPA32 in U2OS-RPA21
cells was complicated by the presence of additional
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Figure 2. Replication protein A (RPA) and DDB2 chromatinization following
treatment. (a) 6-TG/UVA. HeLa, U2OS, or U2OS-RPA21 cells grown for
24 hours in 1, 4, or 10 μM 6-TG, respectively, to ensure equivalent DNA
substitution were UVA irradiated (20 kJ m−2). Whole-cell extracts were
analyzed by western blotting for RPA70. (b) Ciproﬂoxacin/UVA and
Oﬂoxacin/UVA. U2OS or U2OS-RPA21 cells were treated with 0.5 mM
ciproﬂoxacin or oﬂoxacin as indicated and irradiated with UVA (20 kJ m−2).
Whole-cell extracts were analyzed as in a. (c) DDB2. U2OS cells treated
with 6-thioguanine (6-TG) for 24 hours or ﬂuoroquinolone for 1 hour at the
concentrations shown were UVA irradiated as indicated. Whole-cell extracts
prepared immediately after irradiation were analyzed by western blotting for
DDB2 or DDB1/ β-actin as loading controls.
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constitutive RPA forms generated by incomplete processing of
the full-length GFP-RPA polypeptide encoded by the con-
struct (Supplementary Figure S1 online). In addition to the
three correctly processed RPA proteins, U2OS-RPA21 extracts
contained low but detectable levels of polypeptides corre-
sponding to full-length GFP/RPA14-RPA70-RPA32 (143 kDa)
and RPA32-RPA70 fusion polypeptides (102 kDa; Supple-
mentary Figure S1 online). 6-TG/UVA-treated U2OS-RPA21
extracts contained an RPA32 species, apparently identical to
that induced in U2OS cells. This migrated slightly behind the
incompletely processed constitutive 102 kDa RPA32-RPA70
product (Figure 3a). These extracts also contained an
additional RPA32-reactive polypeptide of 70–100 kDa that
was not present in extracts from untreated cells (Figure 3a).
The antioxidant allopurinol suppressed the formation of both
100 and 70–100 kDa complexes, consistent with oxidation-
dependent formation. Neither complex was detected after
exposure to IR, UVC, or hydroxyurea, all of which inhibited
DNA replication by 490% indicating that they are not
generated in response to extensive DNA damage or replica-
tion arrest. Ciproﬂoxacin/UVA (Figure 3b) and oﬂoxacin/UVA
(Figure 3c) generated an apparently identical 100 kDa RPA32
species. Consistent with the induction of a lower level of
overall protein oxidation (Peacock et al., 2014), this complex
was less prominent following oﬂoxacin/UVA treatment. The
enrichment provided by nuclear extracts (see Supplementary
Figures S3 and 4 online) conﬁrmed its presence in oﬂoxacin/
UVA-treated cells. Additional complexes with apparent
masses between 40 and 50 kDa and 70–100 kDa were
observed in extracts from ciproﬂoxacin/UVA-treated U2OS
and U2OS-RPA21 cells, respectively. These changes in
RPA32 were not restricted to U2OS osteosarcoma cells, and
both ciproﬂoxacin/UVA and oﬂoxacin/UVA induced the
100 kDa and 40–50 kDa RPA species in untransformed
GM8339 human ﬁbroblasts (Supplementary Figure S3 online).
The sizes of the RPA photoproducts are consistent with
covalent cross-linking of RPA32 to its RPA neighbors. The
100-kDa species is a potential RPA32:RPA70 dimer. RPA32-
RPA14 dimerization is consistent with the 40–50 kDa species
observed in U2OS and GM8339 cells. In U2OS-RPA21 cells,
the GFP protein fused to RPA14 would contribute an
additional 27 kDa to an RPA32:RPA14 complex to generate
the 70–100 kDa species. To address these possibilities, RPA32
immunoprecipitated from ciproﬂoxacin/UVA-treated U2OS-
RPA21 cells was probed for the presence of RPA70 by
western blotting. Consistent with the presence of a partially
processed GFP-RPA polypeptide, the material immuno-
precipitated from untreated cells included an antiRPA70-
reactive species of ~ 100 kDa (Figure 4a). Ciproﬂoxacin/UVA
increased the amount of antiRPA70 reactive material at
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around 100 kDa, consistent with the formation of an
RPA32:70 dimer. In Figure 4a, this photoproduct is not
resolved from the endogenous unprocessed material. We
conclude that one of the oxidation products of these
photosensitizers is a covalent complex of RPA32 and
RPA70 subunits.
Cysteine residues in RPA have important structural and
functional roles. We therefore examined RPA cysteine thiol
(-SH) oxidation to cysteine sulfenate (Cys-SOH). To do this,
protein sulfenates in extracts of treated U2OS-RPA21 cells
were selectively derivatized with a probe (BP-1), which
comprises a sulfenate-reactive group attached to biotin (Qian
et al., 2011), to enable their recovery via afﬁnity binding to
streptavidin. Western blotting conﬁrmed that ciproﬂoxacin/
UVA and oﬂoxacin/UVA induce the ~100 kDa RPA32:70
complex in U2OS-RPA21 cells (Input, Figure 4b and c). BP-1
derivatized RPA32 was present in untreated and treated
U2OS-RPA21 cells, and the level was increased by both
ciproﬂoxacin/UVA and oﬂoxacin/UVA (Figure 4b and c).
These ﬁndings demonstrate that ﬂuoroquinolone/UVA treat-
ment causes RPA cysteine thiol oxidation. They also suggest
that some RPA may contain Cys-SOH under normal oxic
growth conditions, at least when it is overexpressed. Both
intersubunit cross-linking and cysteine sulfenation are poten-
tial contributors to RPA inactivation and NER inhibition in
oxidatively stressed cells.
RPA damage and in vitro NER
Protein damage underlies the inhibitory effects of ﬂuoroqui-
nolone/UVA on NER (Peacock et al., 2014). Consistent with
previous observations, in vitro assays revealed that extracts
from ciproﬂoxacin/UVA- or oﬂoxacin/UVA-treated U2OS
cells were defective in NER. Similar treatments caused a
more modest reduction in NER capacity of nuclear extracts
from U2OS-RPA21 cells (Figure 5). Probing the extracts for
RPA32 revealed that impaired NER activity coincided with the
appearance of an RPA32 species of ~ 100 kDa.
The relationship between the 100-kDa RPA32 species and
NER capacity was investigated further in extracts of CCRF-
CEM cells. NER inhibition by ciproﬂoxacin/UVA and oﬂox-
acin UVA in CCRF-CEM cells was demonstrated previously
(Peacock et al., 2014; Supplementary Figure S4 online upper
panels). In agreement with the observations with U2OS,
examination of NER-negative extracts from ciproﬂoxacin/
UVA- or oﬂoxacin/UVA-treated CCRF-CEM cells revealed
novel RPA32 species of ~ 100 kDa and 40–50 kDa
(Supplementary Figure S4 online lower panels). Neither
RPA32 complex was observed in NER-competent extracts
from untreated, UVA-irradiated, or drug-treated cells.
We conclude that these ﬂuoroquinolone/UVA combina-
tions cause sufﬁcient oxidative RPA damage to compromise
NER. Damage includes RPA subunit cross-linking and thiol
oxidation. Modest RPA overexpression provides sufﬁcient
RPA to prevent NER becoming compromised.
DISCUSSION
Our observations indicate that, despite its manifest impor-
tance in DNA processing, RPA is limiting for NER under
oxidative stress conditions. Oxidative RPA damage compro-
mises NER, and modest RPA overexpression is sufﬁcient to
prevent this. RPA, and therefore NER, was shown to be
surprisingly susceptible to inhibition under the oxidative stress
conditions induced by photosensitizers. Diminished NER
capacity was associated with readily detectable forms of
damaged RPA.
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RPA is essential for the NER of the UV-induced photole-
sions that are a major cause of skin cancer. In addition, it is
also recruited to the extensive regions of exposed single-
stranded DNA at replication forks stalled by UV-induced
lesions. Cells exposed to UV radiation therefore experience
conﬂicting demands on a limiting RPA pool. In conditions of
extreme replication stress and in the absence of a functional S
phase checkpoint to prevent replicon ﬁring, RPA levels are
insufﬁcient to protect stalled replication forks from collapse
and DNA breakage ensues (Toledo et al., 2013). This
observation has prompted the suggestion that NER capacity
is reduced by RPA sequestration at arrested replication forks
(Tsaalbi-Shtylik et al., 2014) even in cells with a functional
checkpoint. Although this appears to be the case under
conditions of extreme replication stress induced by
hydroxyurea, the extent to which these events occur
following replication arrest by DNA photolesions is unclear.
Ciproﬂoxacin/UVA and 6-TG/UVA inhibit NER (Peacock
et al., 2014). Consistent with enhanced removal of potentially
lethal DNA lesions, improved NER in RPA-overexpressing
U2OS-RPA21 cells decreased their sensitivity to killing by
ciproﬂoxacin/UVA and 6-TG/UVA. Ciproﬂoxacin/UVA is a
source of replication-arresting To4T CPDs that are canoni-
cal NER substrates (Lhiaubet-Vallet et al., 2009).
Chromatinization of both RPA and DDB2 (Otrin et al.,
1997) after ciproﬂoxacin/UVA treatment is consistent with
the presence of CPDs. 6-TG/UVA also induced RPA and
DDB2 relocation, indicating that it too generates replication-
blocking NER substrates. Depletion of RPA by sequestration at
arrested replication forks and competition by ciproﬂoxacin/
UVA- and 6-TG/UVA-induced photolesions for NER proteins
are therefore both potential contributors to a reduced NER
capacity.
Several observations indicate that neither RPA sequestra-
tion nor the presence of competing substrates fully accounts
for NER inhibition. First, our measure of NER activity, 6-4Py:
Py removal, is largely independent of DDB2 and proceeds
much more rapidly compared with To4T CPD excision
(Hwang et al., 1999). DDB-recruiting lesions induced by 6-
TG/UVA and ciproﬂoxacin/UVA-induced To4Ts are there-
fore unlikely to be effective competitors of 6-4Py:Py NER.
Second, RPA sequestration following replication arrest is S
phase speciﬁc. In our experiments, both 6-TG/UVA and
ciproﬂoxacin/UVA effectively abolished 6-4Py:Py excision,
indicating that their inhibitory effects are not conﬁned to S
phase. Most pertinently, oﬂoxacin/UVA also inhibited NER,
and increased RPA expression prevented this inhibition.
Oﬂoxacin/UVA is a very weak source of To4T CPDs
(Lhiaubet-Vallet et al., 2009; Peacock et al., 2014). Under
conditions of NER inhibition it is relatively non-toxic, and the
induction of potentially lethal, replication-arresting DNA
lesions cannot explain NER inhibition by oﬂoxacin/UVA.
Thus, although these data do not exclude a contribution of
DNA damage to NER inhibition, the effects of ﬂuoroquino-
lone/UVA and 6-TG/UVA in U2OS and U2OS-RPA21 cells
indicate additional or alternative events that compromise RPA
function.
Our ﬁndings identify oxidation of RPA itself as an important
determinant of NER efﬁciency both in vivo and in vitro.
Inhibitory 6-TG/UVA, ciproﬂoxacin/UVA, and oﬂoxacin/UVA
treatments that severely compromised NER in U2OS cells
induced covalent cross-linking between RPA subunits to
generate RPA32:70 and most likely RPA32:14 dimers. RPA
cross-linking was oxygen dependent and occurred together
with RPA cysteine oxidation to Cys-SOH. Cross-linked RPA
was present in all NER-negative extracts of ciproﬂoxacin/UVA
and oﬂoxacin/UVA-treated U2OS, U2OS-RPA21, and CCRF-
CEM cells but was not detected in NER-competent extracts.
RPA is limiting for NER by cell extracts (Coverley et al., 1991),
and our ﬁndings indicate that even the modest overexpression
in U2OS-RPA21 cells provides signiﬁcant protection against
NER inhibition. Only a small fraction of the total RPA is
present in cross-linked or sulfenated forms in NER-negative
extracts. Although this is consistent with a powerful dominant
negative effect, it seems more likely that the altered RPA
species are markers for more widespread RPA damage.
RPA is redox sensitive and presents a signiﬁcant target for
oxidation (Park et al., 1999; Men et al., 2007). Eleven of its
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Figure 5. Nucleotide excision repair (NER) in vitro. (a) NER assays of nuclear
extracts from U2OS or U2OS-RPA21 cells treated (1 hour) with ciproﬂoxacin
(0.5 mM) or oﬂoxacin (1 mM) and irradiated with 20 kJ m−2 UVA as indicated.
Excision products (indicated) were radiolabeled and analyzed by urea gel
electrophoresis (upper panels). The same nuclear extracts were analyzed by
western blotting (lower panel). The position of the treatment-related RPA32
complex is indicated as *. (b) Excision products were quantitated by GelDoc,
and NER efﬁciency by extracts from drug/UVA-treated cells is expressed
relative to that of extracts from cells treated with drug alone. Means of three to
ﬁve assays of independently prepared extracts.
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ﬁfteen cysteines are located in the 70-kDa subunit. Four in the
C-terminal region form a zinc ﬁnger essential for DNA
replication but apparently dispensable for NER (Lin et al.,
1998). These two pairs of RPA70 cysteines are particularly
sensitive to oxidant-induced disulﬁde formation (Men et al.,
2007). The remaining 11 cysteines were unaffected, and no
cysteine sulﬁnic or sulfonic acid residues were observed. In
our experiments, ﬂuoroquinolone/UVA treatment increased
the levels of RPA Cys-SOH—a reactive cysteine oxidation
product and a marker for protein oxidation. Protein Cys-SOH
can act as a redox switch to regulate redox homeostasis and
signaling pathways (Groitl and Jakob, 2014). These
metastable intermediates can be reduced back to cysteine
or undergo further and largely irreversible oxidation to more
stable cysteine sulﬁnic and sulfonic acids. Importantly, they
can react with other protein functional groups including
amino groups to form sulfenamide cross-links. The RPA32
complexes were resistant to the reducing conditions asso-
ciated with western blotting, consistent with a cross-link of
this nature. In addition to its two cysteines, RPA32 is rather
methionine rich, and these residues are also plausible
candidates for oxidation to sulfoxide (Men et al., 2007). Any
of these oxidative changes to RPA might adversely affect its
structure and are potentially deleterious for its function. In
summary, RPA is particularly susceptible to oxidation
damage, and it is noteworthy in this regard that screens for
protein carbonyls (Peacock, 2014) and DNA–protein cross-
links (M. Guven and PK, unpublished observations) both
identiﬁed cellular RPA as a potential target for oxidative
damage by 6-TG/UVA.
RPA is of critical importance in almost all DNA transac-
tions. It is therefore surprising that RPA levels are limiting and
that its susceptibility to oxidative stress can compromise NER.
Perhaps there are constraints on RPA expression. On the basis
of the oxidation sensitivity of RPA both in vitro (Men et al.,
2007) and in vivo as described here, it is tempting to speculate
that a sensitivity to oxidative damage constrains its expression
level. Protein oxidation is an unavoidable consequence of
aerobic metabolism, and oxidized proteins are generally
detrimental to cellular ﬁtness. If the multiple functions of RPA
require it to be constructed in a way that renders it particularly
vulnerable to oxidation damage, this requirement may
determine its safe expression level. Limiting RPA may
simply represent a trade-off between function and avoidance
of unacceptable levels of protein oxidation.
The photosensitizers we use are associated with clinical
photosensitivity. They amplify the effects of solar UVA, which is
an acknowledged generator of cellular reactive oxygen species.
Our demonstration that RPA is particularly susceptible to
oxidation damage and that this compromises NER serves to
emphasize the importance of protecting the skin against the
effects of the full spectrum of UV wavelengths in sunlight.
MATERIALS AND METHODS
Chemicals
6-TG, ciproﬂoxacin, and oﬂoxacin were obtained from Sigma-
Aldrich.
Cells and UV irradiation
HeLa, U2OS, and U2OS-RPA21 cells (Toledo et al., 2013), kindly
provided by Dr J. Lucas, were grown in Dulbecco’s MEM supple-
mented with 10% fetal calf serum. UVA irradiation was by a UVH 253
lamp (UV Light Technology Limited) with maximum emission at
365 nm. The dose rate was 0.1 kJ m−2 s−1. UVC (254 nm) was
delivered by a Stratalinker UV Cross-linker (Stratagene) at a dose rate
of 10 J m−2 s−1. For experiments that combined drug/UVA treatment
with UVC radiation, drug/UVA treatment preceded UVC irradiation.
Cell viability was determined by the formazan/tetrazolium (MTT)
cell proliferation assay on triplicate samples. All experiments were
repeated at least twice.
6-TG determination
For initial incorporation measurements, HeLa, U2OS, and U2OS-
RPA21 cells were grown for 48 hours in a medium containing 6-TG.
DNA 6-TG was measured as previously described (Zhang et al.,
2007). Initial determinations indicated that the more slowly growing
U2OS-RPA21 cells incorporated two or three times less 6-TG at the
same external 6-TG concentration. In subsequent experiments, 6-TG
concentrations were adjusted to achieve similar 6-TG incorporation
levels during 24-hour growth. DNA 6-TG values (as % DNA G) were
measured in each experiment to ensure comparability.
UVC 6:4 Py:Py measurements
DNA extracted by the QIAamp DNA mini kit (Qiagen) from drug/
UVA and UVC-treated cells was analyzed by ELISA according to the
supplier’s instructions (Cosmo Bio Co). These experiments conﬁrmed
that none of the drug/UVA treatments induces detectable 6:4 Py:Pys
(Peacock et al., 2014), and initial values for UVC-induced 6:4 Py:Py
were in agreement within 10% independently of prior drug/UVA
treatment. Repair data were therefore expressed as a percentage of
the initial lesions at various times after irradiation.
NER assays in vitro
NER by nuclear extracts of treated cells was assayed as described
previously (Gueranger et al., 2014). Each assay was performed with
at least three independent extracts. Excision products were quantiﬁed
by summing band intensities by GelDoc (Bio-Rad). NER efﬁciency
was calculated relative to extracts from cells treated with drug alone.
Immunoblotting
Whole-cell extracts were prepared with radioimmunoprecipitation
assay buffer. Proteins (20 μg) were separated on 10% polyacrylamide
gels (Invitrogen). After transfer, membranes were probed with
antibodies against RPA32, RPA70, DDB1, or DDB2 (Abcam).
Antigen–antibody complexes were visualized using ECL blotting
detection agent (GE Healthcare).
Immunoprecipitation
Cells were lysed in non-denaturing lysis buffer. RPA32 antibody was
incubated with Dynabeads ProteinG (Invitrogen) before addition of
protein extract (500 μg).
Sulfenate labeling and detection
Treated cells were lysed with radioimmunoprecipitation assay buffer
containing 1mM biotin-1,3-cyclopentanedione (BP-1) probe (Kera-
FAST). N-Ethylmaleimide (20mM; Sigma) was immediately added
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and proteins precipitated with acetone. The dried protein pellet was
dissolved in 2% SDS. Protein concentrations were determined by the
BCA assay (Thermo Scientiﬁc). Solubilized proteins were mixed with
M280 Streptavidin Dynabeads (Invitrogen), which were washed
three times with 4 volumes of 0.1% SDS. Following rotation
overnight at 4 °C beads were washed sequentially (30 minutes each)
with 2 M urea, 1 M NaCl, 0.1% SDS/10 mM DTT, and PBS. BP-1-
derivatized proteins were recovered by boiling and analyzed by
western blotting.
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